Figure 1From: Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case reportFamily pedigree. Family pedigree demonstrating affected individuals and unaffected carriers. Current age or age at presentation of atypical hemolytic uremic syndrome are given in years (y) or months (m). Arrow indicates current patient.Back to article page